Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma — Stella

Home/Diffuse Large B-cell Lymphoma/R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

View on ClinicalTrials.gov

Recruiting

Back to Diffuse Large B-cell Lymphoma trials

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Institute of Hematology & Blood Disease Hospital, Tianjin, Tianjin Municipality

Key details

Phase

Early testing / Safety & dosing

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment target

~108 participants

Started

May 2024

Primary completion

June 2026

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.